NCT00292370View on ClinicalTrials.gov

Quetiapine Augmentation for Treatment-resistant PTSD

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

May 31, 2009

Conditions
Combat DisordersStress Disorders, Post-Traumatic
Interventions
DRUG

Open Label (OL) Paroxetine

Open-label Paroxetine

DRUG

Placebo

Double-blind placebo taken with OL paroxetine

DRUG

Quetiapine

Double-blind quetiapine taken with OL paroxetine

Trial Locations (3)

35233

Birmingham VA Medical Center, Birmingham

35404

Tuscaloosa VAMC, Tuscaloosa

29401-5799

Ralph H. Johnson, Charleston

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

VA Office of Research and Development

FED